食品药品监督管理局
医学
医疗器械
药品审批
风险分析(工程)
药品
药理学
生物医学工程
作者
Eric Q. Wu,Kevin Wu,Roxana Daneshjou,David Ouyang,Daniel E. Ho,James Zou
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2021-04-01
卷期号:27 (4): 582-584
被引量:345
标识
DOI:10.1038/s41591-021-01312-x
摘要
A comprehensive overview of medical AI devices approved by the US Food and Drug Administration sheds new light on limitations of the evaluation process that can mask vulnerabilities of devices when they are deployed on patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI